Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose if this pilot study is to determine if a perioperative infusion of 0.2%
ropivacaine via bilateral T3 paravertebral catheters can decrease the incidence of new onset
atrial fibrillation following primary CABG and/or valve surgery and compare a number of
secondary outcomes.